Summary
Boston Scientific Corporation (BSX) filed a Form 8-K on May 11, 2007, reporting key changes approved by stockholders at their Annual Meeting held on May 8, 2007. The most significant development for investors is the approval of amendments to the company's Certificate of Incorporation and Bylaws that declassify the Board of Directors. This change is a notable shift in corporate governance, moving away from staggered terms for directors to an annual election process for all board members. Additionally, the company increased the maximum size of its Board of Directors from 15 to 20 members. These administrative matters, while less impactful than the board declassification, are part of the company's ongoing efforts to adapt its governance structure. Investors should note that the declassification of the board can potentially lead to greater accountability and responsiveness to shareholder interests.
Key Highlights
- 1Stockholders approved amendments to Boston Scientific's Certificate of Incorporation and Bylaws.
- 2The Board of Directors has been declassified, meaning directors will now be elected annually.
- 3The maximum size of the Board of Directors was increased from 15 to 20 members.
- 4These changes were approved at the Annual Meeting of Stockholders on May 8, 2007.
- 5The filing includes the Fifth Amendment to the Amended and Restated Certificate of Incorporation as Exhibit 3.1(i).
- 6The Restated Bylaws are also included as Exhibit 3.1(ii).